These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7769043)

  • 1. Avidity of EBV VCA-specific IgG antibodies: distinction between recent primary infection, past infection and reactivation.
    Gray JJ
    J Virol Methods; 1995 Mar; 52(1-2):95-104. PubMed ID: 7769043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
    J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children.
    Votava M; Bartosová D; Krchnáková A; Crhová K; Kubinová L
    Acta Virol; 1996 Apr; 40(2):99-101. PubMed ID: 8886119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of three ELISA techniques and an indirect immunofluorescence assay for the serological diagnosis of Epstein-Barr virus infection.
    Debyser Z; Reynders M; Goubau P; Desmyter J
    Clin Diagn Virol; 1997 May; 8(1):71-81. PubMed ID: 9248660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
    Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
    J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an Epstein-Barr virus (EBV) immunoglobulin M enzyme-linked immunosorbent assay using a synthetic convergent peptide library, or mixotope, for diagnosis of primary EBV infection.
    Tranchand-Bunel D; Gras-Masse H; Bourez B; Dedecker L; Auriault C
    J Clin Microbiol; 1999 Jul; 37(7):2366-8. PubMed ID: 10364618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
    Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiological study of Epstein-Barr virus infection in Bangladesh.
    Haque T; Iliadou P; Hossain A; Crawford DH
    J Med Virol; 1996 Jan; 48(1):17-21. PubMed ID: 8825705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
    Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P
    J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avidities of IgG directed against viral capsid antigen or early antigen: useful markers for significant Epstein-Barr virus serology.
    Andersson A; Vetter V; Kreutzer L; Bauer G
    J Med Virol; 1994 Jul; 43(3):238-44. PubMed ID: 7931184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection.
    Obel N; Høier-Madsen M; Kangro H
    APMIS; 1996 Jun; 104(6):424-8. PubMed ID: 8774671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Epstein-Barr viral DNA in serum using rapid-cycle PCR.
    Mouritsen CL; Wittwer CT; Reed G; Khan TM; Martins TB; Jaskowski TD; Litwin CM; Hill HR
    Biochem Mol Med; 1997 Apr; 60(2):161-8. PubMed ID: 9169098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serodiagnosis of Epstein-Barr virus infection by using recombinant viral capsid antigen fragments and autologous gene fusion.
    Hinderer W; Lang D; Rothe M; Vornhagen R; Sonneborn HH; Wolf H
    J Clin Microbiol; 1999 Oct; 37(10):3239-44. PubMed ID: 10488185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Epstein-Barr virus-specific antibodies by means of baculovirus-expressed EBV gp125.
    Sánchez-Martínez D; Patton JL; Stewart JA; Pellett PE
    J Virol Methods; 1995 Mar; 52(1-2):145-53. PubMed ID: 7769027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of serological profiles and avidity of specific antibodies in the sera of patients with potential Epstein-Barr virus (EBV) infection.
    Akpolat N; Gedik M; Nergiz S; Bilek H
    Bratisl Lek Listy; 2013; 114(8):460-3. PubMed ID: 23944621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of IgG antibody to Epstein-Barr virus viral capsid antigen in saliva by antibody capture radioimmunoassay.
    Vyse AJ; Knowles WA; Cohen BJ; Brown DW
    J Virol Methods; 1997 Jan; 63(1-2):93-101. PubMed ID: 9015279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of IgG avidity determination in diagnosis of Epstein-Barr virus infection in immunocompetent and immunocompromised patients.
    Vilibic-Cavlek T; Ljubin-Sternak S; Kos L; Mlinaric-Galinovic G
    Acta Microbiol Immunol Hung; 2011 Dec; 58(4):351-7. PubMed ID: 22207292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.